908 Devices (MASS) vs Neuropace (NPCE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
908 Devices (MASS) has outperformed Neuropace (NPCE) over the past year, gaining 32.2% versus a gain of 19.8%. Over five years, NPCE leads with a -18.6% price change compared with -63.2% for MASS. 908 Devices is the larger company by market cap ($476.6 million vs $426.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MASS | NPCE |
|---|---|---|
| Share price | $11.53 | $12.42 |
| Market cap | $476.58M | $426.31M |
| 1-day change | -2.12% | -2.66% |
| YTD return | +124.38% | -17.36% |
| 1-year return | +32.21% | +19.81% |
| 5-year return | -63.23% | -18.57% |
| EPS (TTM) | $-0.94 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.35 | $19.60 |
| 52-week low | $5.03 | $9.22 |
| Distance from 52-week high | -13.62% | -36.63% |
| Analyst consensus | none | none |
| Avg. price target upside | +16.05% | +61.03% |
| Average volume | 404.42K | 169.86K |
| Shares outstanding | 41.33M | 34.32M |
| Employees | 172 | 220 |
| Sector | Industrials | Health Care |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MASS has outperformed NPCE by 12.4 percentage points over the past year.
- The two companies sit in different sectors: 908 Devices in Industrials and Neuropace in Health Care.
About 908 Devices
MASS stock →908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
Industrials · Industrial Machinery/Components · 172 employees
About Neuropace
NPCE stock →NeuroPace, Inc. operates as a medical device company in the United States.
Health Care · Medical/Dental Instruments · 220 employees
MASS vs NPCE FAQ
Which is bigger, 908 Devices or Neuropace?
908 Devices (MASS) is larger, with a market capitalization of $476.58M compared with $426.31M for Neuropace (NPCE).
Which stock has performed better over the past year, MASS or NPCE?
MASS returned +32.21% over the past 12 months, compared with +19.81% for NPCE (price return, excluding dividends). Past performance does not predict future results.
Are 908 Devices and Neuropace in the same industry?
No. 908 Devices is in the Industrials sector, while Neuropace is in Health Care.